mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.4 |